Lomé, August 13, 2026 — The West African region stands at a critical juncture: either continue relying heavily on imported pharmaceuticals or take bold steps toward building a robust domestic health industry. This pivotal reality brought together medical and academic leaders in Lomé on August 12 at the Agora Senghor, laying the groundwork for a transformative overhaul of the region’s healthcare strategy.

The 21st edition of the Federation of West African Pharmacy Students (FESPAO) Scientific and Cultural Conference made one thing clear: the next generation of medical professionals is no longer satisfied with mere budget requests. They are demanding a fundamental shift in approach, moving away from a distribution-focused model toward industrialization, genomic research, and the scientific validation of traditional knowledge.

Local production: a national security imperative

The global pandemic and recent supply chain disruptions have exposed a harsh truth: dependence on foreign pharmaceutical imports is no longer just an economic weakness—it poses a serious threat to national security. This was the central argument driving discussions at the summit.

Professor Gado Tchangbédji, Togo’s Minister Delegate for Higher Education and Research, outlined the government’s new direction under President Faure Essozimna Gnassingbé: positioning innovation and local drug production as the region’s first line of defense against future health crises. To achieve this, the state has pledged substantial support for scientific cooperation and applied research.

Genomic epidemiology and indigenous knowledge take center stage

Yet local production alone won’t suffice if it merely replicates foreign patents. True sovereignty lies in tailoring treatments to Africa’s unique genetic and epidemiological landscape. The Lomé conference emphasized the urgency of genomic epidemiology—developing therapies based on the continent’s genetic diversity, which has long been overlooked in global clinical trials.

Alongside cutting-edge science, the forum championed a cultural resurgence. Experts advocate for the industrialization of traditional medicine, moving beyond informal herbal practices to rigorous clinical validation. The goal? To patent entirely new, Africa-derived active molecules that reflect the continent’s rich pharmacological heritage.

Rethinking the pharmacist’s role

This industrial and scientific ambition faces a critical hurdle: human capital. As the sector evolves, so must academic training. Professor Tchin Darré, Togo’s Minister Delegate for Health and Dean of the Faculty of Health Sciences at the University of Lomé, highlighted the need for curriculum reform. Tomorrow’s West African pharmacist must evolve from a simple dispenser behind a counter into a cutting-edge researcher, a key player in manufacturing, and an expert in validating indigenous knowledge.

With discussions in Lomé ongoing, the 21st FESPAO conference has set a clear objective: turn these academic debates into enforceable public policies. The aim is to ensure universal healthcare access in West Africa no longer hinges on factories located thousands of miles away from patients.

Ultimately, the stakes couldn’t be higher. Without a strong local pharmaceutical industry and research rooted in African realities, West Africa will remain dependent on external solutions. In the face of future pandemics, this dependence could cost lives. True health sovereignty will be measured by the region’s ability to translate these resolutions into concrete action—so every patient can access care designed, validated, and produced on African soil.